28 JANUARY 2011
NORTHERN VENTURE TRUST PLC
INTERIM MANAGEMENT STATEMENT
FOR THE QUARTER ENDED 31 DECEMBER 2010
Northern Venture Trust PLC presents its interim management statement for the
three months ended 31 December 2010. This constitutes the company's first
interim management statement for the financial year ending 30 September 2011, as
required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.
This statement has been prepared solely to provide additional information in
order to meet the requirements of the Disclosure and Transparency Rules and
should not be relied on by shareholders, or any other party, for any other
purpose.
The unaudited net asset value per ordinary share as at 31 December 2010 was
82.2p (30 September 2010 (audited) 85.2p). The net asset value is stated after
deducting the final dividend of 4.5p per share in respect of the year ended 30
September 2010, which was approved by shareholders at the annual general meeting
on 16 December 2010 and was paid to eligible shareholders on 17 December 2010.
For the purposes of calculating the net asset value per share, quoted
investments are carried at bid prices as at 31 December 2010 and unquoted
investments are carried at fair value as at 31 December 2010 as determined by
the directors.
On 17 December 2010 the company allotted 427,137 new ordinary shares at a price
of 80.7p per share pursuant to the company's dividend reinvestment scheme. On
20 December 2010 the company purchased for cancellation 5,913,941 existing
ordinary shares at a price of 78.3p per share in accordance with the terms of
the tender offer announced on 16 November 2010. On 23 December 2010 the company
allotted 2,367,338 new ordinary shares at a price of 86.0p per share pursuant to
the company's public offer of shares for subscription in the 2010/11 and
2011/12 tax years. The number of ordinary shares in issue at 31 December 2010
was 56,019,952.
On 12 January 2011 the company allotted a further 3,251,840 new ordinary shares
at a price of 86.0p per share pursuant to the company's public offer of shares
for subscription in the 2010/11 and 2011/12 tax years.
During the three months ended 31 December 2010 the following significant
investment transactions took place:
New investments:
Amount
Name of company Business activity invested
£000
Brady (AIM quoted) Trading and risk management software for the 142
commodity sector
Cawood Scientific Analytical laboratory testing services for 1,073
land-based industries
IS Pharma (AIM quoted)* Speciality pharmaceuticals and medical devices 149
*Additional investment in existing portfolio company
Disposals:
None
The directors are not aware of any other events or transactions which have taken
place between 30 September 2010 and the date of publication of this statement
and which have had a material effect on the financial position of the company.
Enquiries:
Alastair Conn/Christopher Mellor, NVM Private Equity Limited - 0191 244 6000
Website:Â www.nvm.co.uk
Neither the contents of the NVM Private Equity Limited website nor the contents
of any website accessible from hyperlinks on the NVM Private Equity Limited
website (or any other website) is incorporated into, or forms part of, this
announcement.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Northern Venture Trust PLC via Thomson Reuters ONE
[HUG#1483456]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.